Clinical Research Services

Clinixir offers end-to-end clinical trial management solutions, providing sponsors with comprehensive support at every stage of the clinical research process from study design and regulatory submission to  compliance, pharmacovigilance, site management, and data management.

Clinical Research Services

Clinixir offers end-to-end clinical trial management solutions, providing sponsors with comprehensive support at every stage of the clinical research process from study design and regulatory submission to  compliance, pharmacovigilance,
site management, and data management.

CU
Logo-TMS
MU
CMU
Logo_KK
Logo_PSK
Clinix_Uni-CU-02
Clinix_Uni-TU
Clinix_Uni-MU-Rama
Clinix_Uni-MU-Tropical
Clinix_Uni-MU-Srisirat
Clinix_Uni-CMU-02
Clinix_Uni-Khonkaen
Clinix_Uni-Songkla
Clinix_Uni-Ubon

Areas of Expertise

Clinixir brings operational excellence and regulatory insight to a broad range of therapeutic areas. With strong site partnerships, deep regional understanding, and experience supporting both global and local sponsors, we help deliver high-quality, efficient trials across Thailand. Our services span from early-phase planning to post-approval support—tailored to the specific demands of each therapeutic area.

CLX_icon_RWE
Oncology
Oncology trials are among the most complex and resource-intensive in clinical research. 
CLX_icon_RWE
Metabolic Diseases
Oncology trials are among the most complex and resource-intensive in clinical research. 
CLX_icon_RWE
Infectious Diseases
Oncology trials are among the most complex and resource-intensive in clinical research. 
CLX_icon_RWE
Herbal Medicines
Oncology trials are among the most complex and resource-intensive in clinical research. 
CLX_icon_RWE
Rare Diseases
Oncology trials are among the most complex and resource-intensive in clinical research. 
CLX_icon_RWE
Medical Devices
Oncology trials are among the most complex and resource-intensive in clinical research. 
CLX_icon_RWE
Neurology
Oncology trials are among the most complex and resource-intensive in clinical research. 
CLX_icon_RWE
Other Therapeutic Areas
Oncology trials are among the most complex and resource-intensive in clinical research. 

Areas of Expertise

Clinixir brings operational excellence and regulatory insight to a broad range of therapeutic areas. With strong site partnerships, deep regional understanding, and experience supporting both global and local sponsors, we help deliver high-quality, efficient trials across Thailand. Our services span from early-phase planning to post-approval support—tailored to the specific demands of each therapeutic area.

  • Mask group-2

    Oncology trials are among the most complex and resource-intensive in clinical research. Clinixir supports sponsors with full-service project management, access to leading cancer centers, and collaboration with top-tier oncologists across Thailand. Our ability to navigate evolving regulatory requirements and manage long-term, data-heavy studies ensures trials are conducted with precision and compliance.

  • Mask group-1

    Thailand faces a growing burden of metabolic disorders, making it an ideal environment for studying treatments for conditions such as diabetes, obesity, and NASH. Clinixir works closely with experienced investigators and urban hospital networks to deliver trials that reflect local disease prevalence. We bring proven strategies for protocol adaptation, lifestyle-related variable management, and data-driven decision-making.

  • Mask group-7-1

    With its tropical climate and diverse patient population, Thailand is well-positioned for infectious disease research, including dengue, COVID-19, hepatitis, and tuberculosis. Clinixir leverages strong public-private site partnerships and a responsive regulatory framework to support fast-start trials and high-volume enrollment. Our local insight is key in managing outbreak-related studies and public health-focused research.

  • Mask group-6

    As a region rich in traditional medicine, Thailand offers unique opportunities for evidence-based research on herbal and botanical therapies. Clinixir provides expertise in designing studies that meet international standards while respecting local practices. We work closely with academic institutions and regulatory bodies to ensure product safety, consistency, and scientific validity throughout the research process.

  • Mask group-4

    Conducting rare disease trials requires specialized recruitment strategies and high coordination across stakeholders. Clinixir helps sponsors overcome challenges in patient identification and retention by leveraging Thailand’s academic networks and referral systems. We also support early engagement with regulatory authorities to streamline study approvals and orphan drug considerations.

  • Mask group

    Device trials require tailored protocols, usability evaluations, and precise regulatory alignment. Clinixir supports both diagnostic and therapeutic device studies, from feasibility through post-marketing. Our familiarity with Thailand’s Medical Device Control Division and hands-on experience managing combination product trials allows us to guide sponsors through compliant and efficient development.

  • Mask group-7

    Neurological research demands careful site selection, complex endpoint monitoring, and long-term follow-up. Clinixir supports trials in Alzheimer’s, Parkinson’s, epilepsy, and neurodevelopmental disorders, with access to leading neurologists and specialist centers. We focus on ensuring data quality and patient continuity throughout lengthy trial durations, while maintaining adherence to global best practices.

  • Mask group-1

    Clinixir actively supports clinical trials in advanced and evolving therapeutic areas, including cell and gene therapies such as CAR-T cell therapy. These studies demand complex regulatory navigation, specialized site coordination, and high standards of operational execution—all areas where our team delivers with confidence.

    We remain open and responsive to supporting sponsors working in innovative or highly specialized fields beyond traditional trial models. With strong institutional partnerships, experienced project teams, and a flexible operational framework, Clinixir is well-positioned to adapt to new study designs and cutting-edge therapies as they emerge.

    As the clinical research landscape evolves, we continue to expand our capabilities to meet the future of medicine.

Why Clinixir

  • Our team of qualified clinical research associates, specialists and project managers utilizes innovative databases in our clinical trial services to ensure that all your projects are delivered in a timely manner and meets international standards.
  • Our team members are certified by the International Conference on Harmonization of Good Clinical Practice (ICH-GCP). They ensure that the integrity of data collected, the rights and safety of the participants, and the quality of the clinical products used to conduct the trials meet international standards. Specifically, our professionals are certified in: GCP for Clinical Investigations of Devices, GCP for Clinical Trials with Investigational Drugs and Biologics (ICH Focus), GCP for Clinical Trials with Investigational Drugs and Medical Devices (U.S. FDA Focus), and Good Manufacturing Practices.
  • We recognize the importance of partnerships with academic institutions in driving medical innovation and clinical solutions. Clinixir was founded by eight renowned medical universities in Thailand, and this partnership provides full support of all clinical trial phases, from Ethics Committee submission to patient recruitment.
  • Our professional team is well-versed in the intricacies of medical device studies and therapeutic areas of clinical research. By drawing from diverse expertise, our clinical research services ensure that your new treatment is fully-researched and reaches successful market access.
  • Our talented individuals work closely with clinical research centers across Thailand to ensure that we achieve the best possible outcome for each clinical case. Clinixir’s specialists have worked on several multi-center and multi-regional projects – allowing us to navigate through every type of project.
  • We are recognized for our leading scientific expertise in value proposition strategy development and evidence generation for all stakeholders. Clinixir has an established reputation for our strong capabilities in publication and facilitating healthcare decision-making backed by scientific evidence.

Our Case Studies

Our case studies highlight the real-world impact of our work. Each project showcases our strategic approach, innovative solutions, and commitment to delivering measurable results. Dive in to see how we've helped our clients overcome challenges, drive growth, and make a difference in their fields.

Clinix_Home_04

Progress Highlights: Phase II/III Immunotherapy Trial for Advanced Liver Cancer

Clinixir’s strength in site management and its unwavering focus on quality and efficiency continue to drive the success of this impactful study. We remain committed to accelerating access to innovative immunotherapies in the region.

Read More →

Latest News & Updates

Discover our latest news and updates to stay on top of clinical research trends and topics such as decentralized clinical trials, pharmacovigilance, treatment development, medical innovations, clinical trial phases, careers in clinical research, and much more.

Advancing Healthcare Decision-Making Through Network Meta-Analysis

Advancing Healthcare Decision-Making Through Network Meta-Analysis

May 30, 2025 2:38:19 PM 2 min read
Progress Highlights: Phase II/III Immunotherapy Trial for Advanced Liver Cancer

Progress Highlights: Phase II/III Immunotherapy Trial for Advanced Liver Cancer

May 26, 2025 11:14:05 AM 2 min read
Is Your EDC System Future-Proof?

Is Your EDC System Future-Proof?

May 23, 2025 10:21:28 AM 4 min read
Frame 9-3

For More Information

For any inquiries or if you require assistance, please don’t hesitate to contact our team—we’re here to help.
"I am very pleased to update everyone that the First Country Subject has been enrolled by Thailand Team on 11 October 2023 at site THA-764-002! After all from the start up process up to getting the approval, trainings, documentations, we have finally made it. I know this is not easy, So I want to take this opportunity to give thanks to the site, Clinixir and to the AZ Thailand study team for your hard work!"
“Tech Observer would like to thank Clinixir for your close collaboration with the sponsor and us during the recent PY8 application process. Your diligent efforts in supporting the sponsor and coordinating with the sites to obtain the necessary documents for PY8 are commendable. Additionally, Clinixir's attendance for a telephone conference with the sponsor on short notice is highly appreciated. The sponsor is deeply thankful for your dedication and support. Thank you.!”
“I am delighted to hear the news and I extend my heartfelt congratulations to each one of your team for reaching this milestone. It reflects the dedication and hard work put forth through exceptional teamwork. Let us carry forward the momentum, enthusiasm, and collaborative spirit to achieve the upcoming milestones. Great job team.”
“We are highly impressed with Clinixir's team, whose professionalism and expertise have greatly contributed to the success of our project.”
“The Sponsor extends their gratitude to K Purada and the Clinixir CRAs/CTA for their invaluable assistance and dedication in successfully cleaning and locking the ChulaVac006 database for the project's interim analysis as planned on February 16, 2024. Your efforts are greatly appreciated.”
“Thank you for your kind support in ensuring the cleaning and locking of the ChulaVac006 interim analysis database as planned. The sponsor greatly appreciates your dedication.Suttipong Chinkrua.”

Subscribe to Our Monthly Newsletter

Sign up to our monthly newsletter to get the latest news and updates delivered directly in your inbox